In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis
Author:
Affiliation:
1. Center for Tuberculosis Research, Johns Hopkins University School of Medicine, 1550 Orleans Street, Baltimore, MD 21287, USA
Funder
National Institutes of Health(NIH)
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Link
http://academic.oup.com/jac/article-pdf/72/8/2320/24332435/dkx152.pdf
Reference37 articles.
1. Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis;Hugonnet;Science,2009
2. In vitro cross-linking of peptidoglycan by Mycobacterium tuberculosis L,D-transpeptidases and inactivation of these enzymes by carbapenems;Cordillot;Antimicrob Agents Chemother,2013
3. Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic;Dhar;Antimicrob Agents Chemother,2015
4. Carbapenems and rifampin exhibit synergy against Mycobacterium tuberculosis and Mycobacterium abscessus;Kaushik;Antimicrob Agents Chemother,2015
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mavintramycin A is a promising antibiotic for treating Mycobacterium avium complex infectious disease;Antimicrobial Agents and Chemotherapy;2024-03-06
2. Mechanism of PK/PD-based Combination of Biapenem and Other Antibiotics on Antibacterial Activity of Pseudomonas aeruginosa in Vitro;J BIOL REG HOMEOS AG;2024
3. Mycobacterium tuberculosis: Pathogenesis and therapeutic targets;MedComm;2023-09-04
4. Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis;Microbiology Spectrum;2023-08-17
5. The In vitro activity of carbapenems alone and in combination with β-lactamase inhibitors against difficult-to-treat mycobacteria; Mycobacterium tuberculosis, Mycobacterium abscessus, and Mycobacterium avium complex: A systematic review;INT J MYCOBACT;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3